Skip to content

VIR VIR BIOTECHNOLOGY INC

Follow

COM (common), issuer CIK 1706431

207 managers (213 13F filers) reported a position in VIR shares at 2025-09-30, 107,012,033 shares in all. 28 filers opened a position and 26 filers sold out during the quarter.

Managers
207
13F filers
213
New
28
Added
61
Reduced
81
Sold out
26
Shares held by filers
107,012,033

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2025

Filers in the available 13F reports with a share position at 2025-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Cornerstone Planning Group LLC13$450<0.01%-8713F-HRTimeline
FARMERS & MERCHANTS INVESTMENTS INCin group FARMERS & MERCHANTS INVESTMEN…60$343<0.01%013F-HRTimelineGroup
Farther Finance Advisors, LLC49$280<0.01%-13513F-HRTimeline
Parkside Financial Bank & Trust40$229<0.01%-2313F-HRTimeline
Bell Investment Advisors, Inc27$155<0.01%013F-HRTimeline
NewEdge Advisors, LLC20$114<0.01%013F-HRTimeline
Covestor Ltd11$00%013F-HRTimelineValue filed as zero, left out of ratios.

Events

  • Sawaf Aziz reported holdings of VIR shares in a Form 3 filed 2026-10-06. 0001628280-26-065222

    Accepted , ingested